Doxofylline Tablet 200 mg, 400 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 200 mg, 400 mg
Reference Brands: -
Category: Respiratory Disorder
Doxofylline 200 mg and 400 mg tablets, a methylxanthine bronchodilator for maintenance in asthma and COPD. For importers, distributors and respiratory tender buyers in markets where doxofylline is registered.
Manufacture or export Doxofylline Tablet? List it or send an offer →
Product Description:
Doxofylline is a methylxanthine bronchodilator, related to theophylline but with a dioxolane group at position 7. It relaxes bronchial smooth muscle, mainly through phosphodiesterase inhibition. Unlike theophylline it has little affinity for adenosine receptors, the usual explanation for the fewer cardiac and gastric effects reported in comparative studies. This page covers 200 mg and 400 mg tablets, the main form for oral maintenance; syrups and injections exist in some markets.
It is used for maintenance in bronchial asthma and in COPD with bronchospasm, usually alongside inhaled therapy rather than in place of it. The usual adult dose is 400 mg two or three times daily, and the 200 mg tablet allows lower or stepwise dosing where the label permits. Labels advise caution in heart disease, hypertension, hyperthyroidism, peptic ulcer and liver or kidney impairment. It should not be combined with other xanthines such as theophylline. Erythromycin and other drugs that slow xanthine clearance may raise its levels.
Sourcing notes. Doxofylline is registered in India, Italy and a number of other markets, but not by the US FDA, so confirm approval in your destination. Combinations with other respiratory drugs are sold in some places; check that any combination is approved in your market. A CTD or ACTD dossier should include dissolution data, bioequivalence where required and zone IVb stability for hot, humid climates. Tablets ship at room temperature in Alu-Alu or PVC blisters. Ask the supplier for a per-batch CoA, a valid GMP certificate and a CoPP.
Doxofylline Tablet — third party manufacturing & bulk supply
Doxofylline Tablet 200 mg, 400 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Doxofylline Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Doxofylline Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Doxofylline Tablet →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Doxofylline is used for the treatment and management of respiratory conditions such as bronchial asthma, chronic obstructive pulmonary disease (COPD), and other diseases associated with bronchospasm.
Doxofylline is a synthetic xanthine derivative that acts as a bronchodilator by relaxing the smooth muscles of the airways.
It is marketed under various trade names such as Doxolin Syrup, Doxofyl Syrup, Doxotab Syrup, and other regional brands.
More than one company makes it, including manufacturers in India. Share your market and we will find licensed makers whose documents fit.
The generic name is Doxofylline.
Common brand names include Doxolin, Doxofyl, Doxotab, and other region-specific brands.
Doxofylline syrup is primarily manufactured in India and also produced in other regions such as Europe, Latin America, and Southeast Asia by various pharmaceutical companies.
Related Products
Ethofylline & Theophylline Injection
Strength:
84.7 mg Ethofylline + 25.3 mg Theophylline
Form: Injection
Reference Brands: Deriphyllin®
View DetailsGlycopyrrolate + Indacaterol
Strength:
Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg
Form: Inhalation powder delivered via Neohaler device/Breezhaler device
Reference Brands: Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU)
View DetailsIsoniazid Tablet
Strength:
100 mg, 300 mg
Form: Tablet
Reference Brands: Nydrazid®(US); Rimifon® (Germany)
View DetailsGlycopyrrolate / Formoterol
Strength:
Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg
Form: Pressurized metered-dose inhaler (pMDI)
Reference Brands: Bevespi Aerosphere(US)
View DetailsFlunisolide
Strength:
250 mcg
Form: Inhalation solution
Reference Brands: AeroBid (USA)
View DetailsMetaproterenol Sulfate
Strength:
10 mg, 15 mg,5 mg/5 m
Form: Tablet / Syrup / Inhalation Solution
Reference Brands: -
View DetailsMethacholine Chloride
Strength:
0.25 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL
Form: Inhalation solution
Reference Brands: Provocholine (USA)
View DetailsOlodaterol
Strength:
2.5 mcg
Form: Inhalation solution
Reference Brands: Striverdi Respimat (USA)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit